Results 121 to 130 of about 76,191 (305)

Mixed lymphocyte reactions do not predict severity of graft versus host disease (GVHD) in HLA-DR compatible, sibling bone marrow transplants. [PDF]

, 1988
Sora Lim, W. N. Patton, Shirley Jobson, T. A. Gentle, M Baynham, Ian M. Franklin, B J Broughton   +6 more
openalex   +1 more source

Relapsed/Refractory Follicular Lymphoma: Current Advances and Emerging Perspectives

European Journal of Haematology, Volume 114, Issue 5, Page 775-784, May 2025.
ABSTRACT Follicular lymphoma (FL) is a prevalent indolent non‐Hodgkin lymphoma (NHL) characterized by a relapsing course and eventual refractoriness to therapy. Despite advancements in treatment, FL remains incurable, necessitating ongoing research into novel therapeutic strategies.
Giulio Caridà, Enrica Antonia Martino, Antonella Bruzzese, Daniele Caracciolo, Caterina Labanca, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Teresa Rossi, Antonino Neri, Ernesto Vigna, Pierfrancesco Tassone, Pierosandro Tagliaferri, Fortunato Morabito, Massimo Gentile   +14 more
wiley   +1 more source

Pathogenic mechanisms of Acute Graft versus Host Disease

Revista Brasileira de Hematologia e Hemoterapia, 2002
Graft-versus-host-disease (GVHD) is the major complication of allogeneic Bone Marrow Transplant (BMT). Older BMT recipients are a greater risk for acute GVHD after allogeneic BMT, but the causes of this association are poorly understood.
Ferrara James L.M.
doaj  

MataHari reveals secrets of GVHD [PDF]

Blood, 2012
The name Mata Hari is synonymous with espionage and secrecy, and in this issue of Blood the “MataHari” mouse has helped Toubai and colleagues reveal the role that nonhematopoietic antigen presentation plays in initiating graft-versus-host disease (GVHD).[1][1] Since the seminal study ...
openaire   +3 more sources

Allogeneic Haematopoietic Stem Cell Transplantation Using Reduced‐Intensity Fludarabine, Busulfan and Anti‐T‐Lymphocyte Globulin With Strategic Donor Lymphocyte Infusion in Older Patients With Myeloid Malignancy

European Journal of Haematology, EarlyView.
ABSTRACT Fludarabine, busulfan, and anti‐T‐lymphocyte globulin (FLUBU3+ATLG) reduced‐intensity conditioning is an established preparative regimen for allogeneic haematopoietic stem cell transplantation in older patients with myeloid malignancy. We examined its modern‐day performance in 175 sequentially treated patients on our national programme ...
Chris Armstrong, Eibhlin Conneally, Catherine Flynn, Paul Browne, Mairead Ni Chonghaile, Carmel Ann Galligan, Hayley Foy‐Stones, Nicola Gardiner, Greg Lee, Nina Orfali   +9 more
wiley   +1 more source

Medical and Nutritional Outcomes Are Similar Among Autologous Transplant Patients on Enteral Nutrition When Compared to Parenteral Nutrition. A Randomized Pilot Study

European Journal of Haematology, EarlyView.
ABSTRACT Autologous hematopoietic stem cell transplantation (AHSCT) is the treatment for myeloma and lymphoma. posttreatment, significant nutritional and medical issues and malnutrition assessed by Subjective Global Assessment (SGA) arise. No established effective treatment for using either parenteral (PN) or enteral routes (EN) to improve nutritional ...
Janet Madill, Brenda Hartman, Heather Resvick, Mehraneh Mohebbi, Alison Andrade, Cheryl Sigfrid, Maisam Abouzeeni, Adrienne Fulford, Anargyros Xenocostas, Uday Deotare   +9 more
wiley   +1 more source

Outcomes of allogeneic haemopoietic transplant for chronic lymphocytic leukaemia in the modern era

Internal Medicine Journal, EarlyView.
Abstract Background Allogeneic haemopoietic stem cell transplantation (HSCT) is an effective therapy with curative potential for patients with high‐risk or relapsed/refractory chronic lymphocytic leukaemia (CLL). There are limited data on the use and outcomes of HSCT in the modern era of CLL treatment.
Luani Barge, Steven Tran, Glen Kennedy, David Ritchie, David Gottlieb, Sam Milliken, Andrew Spencer, Duncan Purtill, Travis Perera, Richard Doocey, Stephen Larsen, Andrew Butler, Peter Bardy, Matthew Greenwood, Simon Durrant, Cameron Curley, Caroline Stewart, Constantine Tam, Shalini Balendran, Pietro R. Di Ciaccio, Sushrut Patil, Min‐Hi Han, Nada Hamad   +22 more
wiley   +1 more source

Preferred Reporting Items for Microbiotherapy (PRIM) Guidelines Across Medical Disciplines: An International Delphi Consensus

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Microbiotherapy has opened new avenues for managing dysbiosis‐related diseases. However, many studies did not cover all the necessary reporting items for microbiotherapy making the interpretation of results, safety assessment, technology extension, and even the transparency of legitimacy difficult. This project consisted of 2 phases. First, we
Faming Zhang, Michael A. Kamm, Xia Wu, Dina Kao, Thomas J. Borody, Lea Ann Chen, Xingxiang He, Monika Fischer, Sunny H. Wong, Siew C. Ng, Bota Cui, Francis K‐L Chan, Yongzhan Nie, Ajit Sood, Jingnan Li, Yang Sun, Ishikawa Dai, Qiyi Chen, Muhan Lv, Zulun Zhang, Gianluca Ianiro, Yunsheng Yang, Colleen R. Kelly   +22 more
wiley   +1 more source

Immunomodulation of salivary gland function due to cancer therapy

Oral Diseases, EarlyView.
Abstract Functional salivary glands (SG) are essential for maintaining oral health, and salivary dysfunction is a persistent major clinical challenge. Several cancer therapies also have off‐target effects leading to SG dysfunction. Recent advances highlight the role of SG immune populations in homeostasis, dysfunction and gland regeneration.
Ana C. Costa‐da‐Silva, Carlos U. Villapudua, Matthew P. Hoffman, Marit H. Aure   +3 more
wiley   +1 more source

A Preliminary Gene Expression Profile of Acute Graft-Versus-Host Disease

Cell Transplantation, 2008
Allogeneic hematopoietic stem cell transplantation (HSCT) is the treatment of choice for high-risk hematological malignancies, yet a major complication associated with this therapy is acute graft-versus-host disease (GVHD).
Matthew P. Buzzeo, Jie Yang, George Casella, Vijay Reddy M.D. Ph.D.   +3 more
doaj   +1 more source